Casati A, Magistris L, Beccaria P, Cappelleri G, Aldegheri G, Fanelli G
Department of Anesthesiology, IRCCS H. San Raffaele, University of Milan, Italy.
Minerva Anestesiol. 2001 May;67(5):407-12.
The aim of this prospective, randomized, double-blind study was to evaluate the effects of adding 1 microg/kg clonidine to 20 ml of ropivacaine 0.75% for axillary brachial plexus anesthesia.
With Ethical Committee approval and written consent, 30 ASA physical status I-II in-patients, undergoing upper extremity orthopedic procedures were randomly allocated to receive axillary brachial plexus block with 20 ml of 0.75% ropivacaine alone (group ropivacaine, n = 15) or 0.75% ropivacaine + 1 microg/kg clonidine (group ropivacaine-clonidine, n = 15). Nerve blocks were placed using a nerve stimulator with the multiple injection technique (stimulation frequency was 2 Hz; stimulation intensity was decreased to < or = 0.5 mA after each muscular twitch; the anesthetic volume was equally divided among arm flexion, arm extension, wrist flexion, and thumb adduction). A blinded observer recorded the time required to achieve surgical block [loss of pinprick sensation in the innervation areas of the hand (C6-C8) with concomitant inability to move the wrist and hand] and first analgesic request.
No differences in demography, degree of sedation, peripheral oxygen saturation, and hemodynamic variables were observed between the two groups. Readiness for surgery required 15 min (5-36 min) with 0.75% ropivacaine and 20 min (5-30 min) with the ropivacaine-clonidine mixture. The degree of pain measured at first analgesic request, and consumption of postoperative analgesics were similar in the two groups; while first postoperative analgesic request occurred after 13.8 h (25th-75th percentiles: 9.1-13 h) in the ropivacaine group and 15.2 h (25th-75th percentiles: 10.7-16 h) in the ropivacaine-clonidine group (p = 0.04).
Adding 1 microg/kg clonidine to 20 ml of ropivacaine 0.75% for axillary brachial plexus anesthesia provided a 3 h delay in first analgesic request postoperatively, without clinically relevant effects on the degree of sedation and cardiovascular homeostasis.
本前瞻性、随机、双盲研究旨在评估在20毫升0.75%罗哌卡因中添加1微克/千克可乐定用于腋路臂丛神经麻醉的效果。
经伦理委员会批准并获得书面同意后,30例拟行上肢骨科手术的ASA身体状况I-II级住院患者被随机分配,分别接受单纯20毫升0.75%罗哌卡因的腋路臂丛神经阻滞(罗哌卡因组,n = 15)或0.75%罗哌卡因+1微克/千克可乐定(罗哌卡因-可乐定组,n = 15)。使用神经刺激器采用多点注射技术进行神经阻滞(刺激频率为2赫兹;每次肌肉抽搐后刺激强度降至≤0.5毫安;麻醉剂体积在屈臂、伸臂、屈腕和拇指内收之间平均分配)。一名盲法观察者记录达到手术麻醉所需时间[手部(C6-C8)神经支配区域痛觉消失且同时无法活动手腕和手部]以及首次镇痛需求时间。
两组在人口统计学、镇静程度、外周血氧饱和度和血流动力学变量方面均未观察到差异。使用0.75%罗哌卡因时,手术准备需要15分钟(5-36分钟),使用罗哌卡因-可乐定混合液时需要20分钟(5-30分钟)。两组首次镇痛需求时的疼痛程度以及术后镇痛药消耗量相似;罗哌卡因组首次术后镇痛需求出现在13.8小时(第25-7百分位数:9.1-13小时),罗哌卡因-可乐定组出现在15.2小时(第25-75百分位数:10.7-16小时)(p = 0.04)。
在20毫升0.75%罗哌卡因中添加1微克/千克可乐定用于腋路臂丛神经麻醉可使术后首次镇痛需求延迟3小时,且对镇静程度和心血管稳态无临床相关影响。